February 3, 2025 - 20:00

WHITE PLAINS, N.Y., February 3, 2025—In a significant leadership change, OPAL Fuels Inc. has announced the appointment of Kazi Hasan as its new Chief Financial Officer, effective immediately. Hasan steps into the role following the tenure of Scott Contino, who has been serving as the interim CFO since October 2023. Contino will maintain his position as Chief Financial Officer for Fortistar, the company’s sponsor.
Kazi Hasan brings a wealth of financial expertise and leadership experience to OPAL Fuels. His appointment is seen as a strategic move to enhance the company's financial operations and support its growth initiatives. The transition comes at a pivotal time for OPAL Fuels as it continues to expand its footprint in the renewable energy sector.
The company expressed confidence in Hasan's capabilities to drive financial strategy and operational efficiency. As OPAL Fuels embarks on its next chapter, stakeholders are optimistic about the direction under Hasan’s leadership.
June 23, 2026 - 20:50
Bitcoin 'vulnerable to further weakness' as token tumbles amid tech routBitcoin took a sharp hit on Tuesday, falling in tandem with a broad sell-off in technology stocks that rattled global markets. The leading cryptocurrency dropped more than 5% in a single session,...
June 23, 2026 - 18:40
SpaceX stock dips below $150 debut before reboundingSpaceX`s stock took another hit on Tuesday, sliding below its initial public offering price of $150 before recovering later in the session. The sell-off extended a rough stretch for the company`s...
June 22, 2026 - 17:54
SpaceX stock tumbles 16.4%, shaving off most IPO gains since debutSpaceX shares took another sharp hit on Monday, putting the company on track for three consecutive days of losses. The steep decline has wiped out the majority of the gains the stock had racked up...
June 22, 2026 - 04:41
West Pharmaceutical Services (WST) Stock Could Be 6.9% Undervalued on GLP 1 Growth NarrativeWest Pharmaceutical Services (WST) stock has drawn attention after recent share price moves, with investors weighing its role in drug containment and delivery in relation to current valuation...